Recombinetics to Develop Alzheimer’s, Neurofibromatosis Swine Models for NIH
Recombinetics has secured a pair of grants worth more than $700,000 combined from two National Institutes of Health organizations to create humanized swine models of Alzheimer’s disease and Neurofibromatosis type 2. The biotechnology company will develop the swine models for the National Institute on Aging and the National Institute of Neurological Disorders and Stroke under NIH’s Small Business Innovative Research […] More